Search

Compugen Ltd

Uždarymo kaina

2.58 1.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.52

Max

2.59

Pagrindiniai rodikliai

By Trading Economics

Pajamos

663K

-7M

Pardavimai

426K

2.6M

P/E

Sektoriaus vid.

6.737

56.659

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-269.254

Darbuotojai

75

EBITDA

665K

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+95.31% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

17M

242M

Ankstesnė atidarymo kaina

1.01

Ankstesnė uždarymo kaina

2.58

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-01 23:56; UTC

Correlated Moves

Shares declined in after-market trading amid rising oil prices.

2026-09-01 23:56; UTC

Cricut Inc shares are lower in after-market trading amid broader market pressures and declining oil prices, reflecting heightened inflation concerns.

2026-09-01 23:56; UTC

Fidelity National Information Services remains near unchanged in after-market trading, with no specific news identified and a position below its 20-day moving average.

2026-09-01 23:56; UTC

monday.com Ltd. shares traded roughly flat in after-market hours. The stock remains above its 20-day moving average and near the upper end of its one-month range.

2026-09-01 23:56; UTC

Cognizant Technology Solutions shares are lower in after-market trading, amid broader market pressure from rising oil prices and geopolitical tensions.

2026-09-01 23:56; UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI products, leading shares to trade lower in after-market hours.

2026-09-01 23:56; UTC

Becton Dickinson and Co shares rose in after-market trading, reflecting a position above its 20-day moving average and near the top of its one-month range.

2026-09-01 23:56; UTC

United States Copper Index Fund is higher in after-market hours, maintaining resilience amid broader market declines driven by rising oil prices and inflation concerns.

2026-09-01 23:56; UTC

Arbor Realty Trust Inc. shares rose in after-market trading, despite broader market pressures and rising oil prices raising inflation concerns among investors.

2026-09-01 23:56; UTC

Travelers Companies Inc shares are lower in after-market hours, with no specific news identified. Rising oil prices contribute to broader inflation concerns affecting equities.

2026-09-01 23:56; UTC

ON Semiconductor shares are lower in after-market hours, reflecting broader market pressure amid rising oil prices and inflation concerns.

2026-09-01 23:56; UTC

Ecolab Inc shares are higher in after-market hours amid rising oil prices and geopolitical tensions, despite broader market pressures from inflation concerns.

2026-09-01 23:56; UTC

Merit Medical Systems Inc shares are higher in after-market hours, reflecting strong performance despite broader market pressures from rising oil prices and inflation concerns.

2026-09-01 23:56; UTC

Martin Marietta Materials Inc. shares are higher in after-market trading, recovering from earlier declines despite ongoing pressures from rising oil prices and inflation concerns.

2026-09-01 23:56; UTC

News

AbbVie Inc. has filed for a new Skyrizi regimen to treat Crohn's disease. Shares are lower in after-market hours amid broader market pressure from rising oil prices.

2026-09-01 23:56; UTC

Geron Corp shares are higher in after-market trading, reflecting a positive move since Tuesday's close amid broader market fluctuations. No specific news was identified.

2026-09-01 23:56; UTC

Check Point Software Technologies shares are lower in after-market trading, following earlier volatility and broader market pressure from rising oil prices.

2026-09-01 23:52; UTC

Clean Harbors Inc shares are lower in after-market trading, declining after a near-flat position. No specific news was identified to explain the movement.

2026-09-01 23:52; UTC

Huntington Bancshares Inc shares are higher in after-market hours, recovering from a session low despite trading below its 20-day moving average.

2026-09-01 23:51; UTC

Bank of Hawaii Corp shares are higher in after-market trading, recovering from an earlier dip. The stock remains below its 20-day moving average.

2026-09-01 23:51; UTC

ETF Constituents
Macro News

iShares MSCI Germany ETF declines in after-market hours amid global equity market pressure from macroeconomic concerns and rising crude oil prices.

2026-09-01 23:51; UTC

News

Telephone and Data Systems withdraws Array Digital Infrastructure acquisition proposal and resumes share repurchase program. Shares rise in after-market trading.

2026-09-01 23:51; UTC

Correlated Moves

Shares of Comfort Systems USA Inc. declined in after-market trading, influenced by broader market sentiment and rising oil prices amid geopolitical tensions.

2026-09-01 23:51; UTC

News
Correlated Moves

EOG Resources shares are higher after the company announced participation in the Barclays Energy-Power Conference, with oil prices surpassing $90 per barrel.

2026-09-01 23:51; UTC

Unity Software Inc. shares are trading higher in after-market hours, breaking from a recent trend of consecutive daily gains.

2026-09-01 23:51; UTC

Correlated Moves
Social Media

ConocoPhillips shares are lower in after-market hours amid broader energy sector scrutiny, despite rising crude oil prices above $90 per barrel.

2026-09-01 23:51; UTC

Verizon Communications Inc shares are lower in after-market hours, with no specific news identified to explain the decline. Oil price increases raise inflation concerns.

2026-09-01 23:51; UTC

European equities decline as oil prices surge and geopolitical tensions rise, fueling inflation fears and bond market sell-off ahead of potential ECB interest rate hikes.

2026-09-01 23:51; UTC

Global equity markets decline as oil prices surge over 5% amid U.S.-Iran tensions, while weak U.S. job openings and Eurozone inflation rise raise concerns over economic stability.

2026-09-01 23:51; UTC

U.S. equity indices decline as rising oil prices and bond yields heighten inflation fears amid geopolitical tensions, with investors bracing for potential stagflation risks.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

95.31% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  95.31%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat